Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.144ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.288ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.288ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.249ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.378ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.5 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.351.5 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.6 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.6 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.9 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used